These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1899060)

  • 1. HPLC analysis of flecainide enantiomers in plasma: comparison with fluorescence polarization immunoassay.
    Alessi-Severini S; LeGatt DF; Pasutto FM; Jamali F; Coutts RT
    Clin Chem; 1991 Jan; 37(1):111-2. PubMed ID: 1899060
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of fluorescence polarisation immunoassay (FPIA) and high performance liquid chromatography (HPLC) methods for the measurement of flecainide in human plasma.
    Hoppe U; Krüdewagen B; Stein H; Hertrampf R; Gundert-Remy U
    Int J Clin Pharmacol Ther Toxicol; 1993 Mar; 31(3):142-7. PubMed ID: 8468112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid chromatography and fluorescence polarization immunoassay methods compared for measuring flecainide acetate in serum.
    Straka RJ; Hoon TJ; Lalonde RL; Pieper JA; Bottorff MB
    Clin Chem; 1987 Oct; 33(10):1898-900. PubMed ID: 3117433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective determination of flecainide in human plasma by high-performance liquid chromatography with fluorescence detection.
    Turgeon J; Kroemer HK; Prakash C; Blair IA; Roden DM
    J Pharm Sci; 1990 Feb; 79(2):91-5. PubMed ID: 2109058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic assay of flecainide and its enantiomers in serum.
    Lie-A-Huen L; Stuurman RM; Ijdenberg FN; Kingma JH; Meijer DK
    Ther Drug Monit; 1989 Nov; 11(6):708-11. PubMed ID: 2512696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of gas-liquid chromatography and fluorescence polarization immunoassay for therapeutic drug monitoring of flecainide acetate.
    Stas CM; Jacqmin PA; Pellegrin PL
    J Pharm Biomed Anal; 1989; 7(12):1651-6. PubMed ID: 2518773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gas chromatography/mass spectrometry validation of high-performance liquid chromatography analysis of flecainide enantiomers in serum.
    Fischer C; Bühl K
    Ther Drug Monit; 1992 Oct; 14(5):433-5. PubMed ID: 1448853
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of fluoroimmunoassays for flecainide.
    Coxon RE; Hodgkinson AJ; Sidki AM; Landon J; Gallacher G
    Ther Drug Monit; 1987 Dec; 9(4):478-83. PubMed ID: 3122378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring of flecainide using high-performance liquid chromatography and comparison with fluorescence polarisation immunoassay.
    Woollard GA
    J Chromatogr; 1989 Feb; 487(2):409-19. PubMed ID: 2498375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct-injection high-performance liquid chromatographic analysis of drug enantiomers in plasma with an avidin column coupled on-line to an ovomucoid column.
    Oda Y; Asakawa N; Yoshida Y; Sato T
    J Pharm Sci; 1992 Dec; 81(12):1227-8. PubMed ID: 1491346
    [No Abstract]   [Full Text] [Related]  

  • 11. Stereoselective analysis of flecainide enantiomers using reversed-phase liquid chromatography for assessing CYP2D6 activity.
    Doki K; Sekiguchi Y; Kuga K; Aonuma K; Kohda Y; Homma M
    Biomed Chromatogr; 2014 Sep; 28(9):1193-8. PubMed ID: 24523024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flecainide: what are we measuring?
    Ray J
    Ther Drug Monit; 1990 Jul; 12(4):416. PubMed ID: 2118694
    [No Abstract]   [Full Text] [Related]  

  • 13. High-performance liquid chromatographic determination of the enantiomers of flecainide in human plasma and urine.
    Alessi-Severini S; Jamali F; Pasutto FM; Coutts RT; Gulamhusein S
    J Pharm Sci; 1990 Mar; 79(3):257-60. PubMed ID: 2110973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of flecainide concentration in blood plasma by HPLC and pharmacokinetic parameters in volunteers].
    Li XY; He JB; Tan WP; Yu ST; Huang W; Sun JP; Yu CH; Qian F
    Yao Xue Xue Bao; 1989; 24(6):452-7. PubMed ID: 2514579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of serum flecainide and its metabolites by using high performance liquid chromatography.
    Doki K; Homma M; Kuga K; Watanabe S; Yamaguchi I; Kohda Y
    J Pharm Biomed Anal; 2004 Sep; 35(5):1307-12. PubMed ID: 15336377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate measurements in plasma: comparison of enzyme multiplied immunoassay technique, TDx fluorescence polarization immunoassay, and high pressure liquid chromatography.
    Slørdal L; Prytz PS; Pettersen I; Aarbakke J
    Ther Drug Monit; 1986; 8(3):368-72. PubMed ID: 3529519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatographic procedure with fluorescence detection for the m-O-dealkylated lactam metabolite of flecainide acetate in human plasma.
    Welscher TM; McQuinn RL; Chang SF
    J Chromatogr; 1988 Oct; 431(2):438-43. PubMed ID: 3149643
    [No Abstract]   [Full Text] [Related]  

  • 18. A high performance liquid chromatographic method for the quantitation of flecainide in plasma.
    Broly F; Marecaux P; Houdret N; Lhermitte M; Houssin R
    Biomed Chromatogr; 1991 Nov; 5(6):248-50. PubMed ID: 1760591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple high-performance liquid chromatographic method for the routine measurement of flecainide in plasma.
    Grgurinovich N
    J Anal Toxicol; 1988; 12(1):38-41. PubMed ID: 3127637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmortem increase of flecainide level in cardiac blood.
    Yoshitome K; Miyaishi S; Yamamoto Y; Ishizu H
    J Anal Toxicol; 2008; 32(6):451-3. PubMed ID: 18652753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.